RIPK3 and metabolic dysfunction-associated steatohepatitis: ,11 Consistent with these findings, we hereby show that RIPK3 is expressed primarily in cholangiocytes in patients with NASH, PSC, and ALD, and recipients undergoing liver retransplantation.